Corcept Therapeutics Incorporated shares owned by Gotham Asset Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Gotham Asset Management
from 13F filings
Historical chart of Gotham Asset Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Corcept Therapeutics Incorporated by Gotham Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $964k | 19k | 50.39 |
2024-09-30 | $862k | 19k | 46.28 |
2024-06-30 | $811k | 25k | 32.49 |
2024-03-31 | $974k | 39k | 25.19 |
2023-12-31 | $574k | 18k | 32.48 |
2023-09-30 | $483k | 18k | 27.25 |
2023-06-30 | $485k | 22k | 22.25 |
2023-03-31 | $633k | 29k | 21.66 |
2022-12-31 | $887k | 44k | 20.31 |
2022-09-30 | $978k | 38k | 25.63 |
2022-06-30 | $1.1M | 47k | 23.77 |
2022-03-31 | $1.1M | 49k | 22.51 |
2021-12-31 | $967k | 49k | 19.80 |
2021-09-30 | $365k | 19k | 19.66 |
2021-06-30 | $338k | 15k | 21.98 |
2021-03-31 | $399k | 17k | 23.82 |
2020-12-31 | $695k | 27k | 26.16 |
2020-09-30 | $755k | 43k | 17.40 |
2020-06-30 | $488k | 29k | 16.82 |
2020-03-31 | $860k | 72k | 11.89 |
2019-12-31 | $945k | 78k | 12.09 |
2019-09-30 | $685k | 49k | 14.14 |
2019-06-30 | $849k | 76k | 11.14 |
2019-03-31 | $1.4M | 116k | 11.74 |
2018-12-31 | $1.6M | 123k | 13.36 |
2018-09-30 | $789k | 56k | 14.02 |
2018-06-30 | $1.1M | 70k | 15.72 |
2018-03-31 | $341k | 21k | 16.46 |
2017-12-31 | $322k | 18k | 18.06 |
2017-09-30 | $1.3M | 67k | 19.29 |
2017-06-30 | $704k | 60k | 11.80 |
2017-03-31 | $128k | 12k | 10.95 |
2016-12-31 | $276k | 38k | 7.26 |
2016-09-30 | $136k | 21k | 6.50 |
2016-06-30 | $82k | 15k | 5.46 |
2015-12-31 | $86k | 17k | 4.96 |
2015-09-30 | $65k | 17k | 3.77 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated